Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
Phase 2
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2007-06-12
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 33
- Registration Number
- NCT00181025
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 100
- Registration Number
- NCT00180960
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
Glivec Phase II Pediatric Study
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 36
- Registration Number
- NCT00180830
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
π³π±Emma Kinderziekenhuis AMC, Amsterdam, Netherlands
π¬π§Birmingham Children's Hospital, Birmingham, United Kingdom
LMBA02 Protocol for Patients With a Burkitt Lymphoma
Phase 3
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 260
- Registration Number
- NCT00180882
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 40
- Registration Number
- NCT00180895
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-08
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 210
- Registration Number
- NCT00180947
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area
Phase 3
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2005-12-23
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 280
- Registration Number
- NCT00180934
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2005-12-14
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 120
- Registration Number
- NCT00180986
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.
Phase 3
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2005-09-16
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 520
- Registration Number
- NCT00180973
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2005-09-16
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 150
- Registration Number
- NCT00180869
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Β© Copyright 2024. All Rights Reserved by MedPath